Pioneering research in Microdosing GLP-1 The AgelessRx Applied Science Team is leading the first clinical trial focused on the healthspan-enhancing potential of Microdosing GLP-1 Ongoing observational study including long-term tracking of diverse health outcomes in over 1,000 patients using a growing real-world database of patient-reported data Clinical collaborations are currently in development to expand the scope and impact of this research How it works GLP-1s bind to GLP-1 receptors beyond the brain and gut, reaching the heart, kidneys, blood vessels, and immune cells Shown to support signaling to longevity-related pathways like AMPK and mTOR, affecting key Hallmarks of Aging like oxidative stress, inflammation, DNA repair, mitochondrial function, and autophagy At low doses, may subtly restore balance to hormone signaling, reduce inflammation (immune cells), improve cognitive function, and cardiometabolic health Effects may vary based on individual biology and with factors including inflammation, weight, lifestyle, metabolic health, and health history

You can view the Certificate of Analysis (CoA) for our Retatrutide here
doi:10.1177/0333102418821661 Post #2027
READ MORE: Shoppers rush to snap up the 35 Amazon hair styler that beauty fans are calling 'life changing' READ MORE: I'm a fashion writer and these 22 M&S sandals could be mistaken for a 610 Hermes pair Adding a cleansing balm to your daily face care is a lovely treat
Evening Primrose and Starflower Oil are some of the few natural sources of the essential fatty acids Omega-6 and gamma-linolenic acid (GLA)
L.ThompsonC